Treatment of documented and suspected neutropenia-associated invasive fungal infections

Journal of Chemotherapy

Volumn 13, Issue SPEC. ISS. 1, 2001, Pages 181-192

  De Pauw, B E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillosis; Disseminated candidiasis; Fungal infection; Neutropenia

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; COTRIMOXAZOLE; FLUCONAZOLE; FLUCYTOSINE; GROWTH FACTOR; ITRACONAZOLE; MICAFUNGIN; NYSTATIN; PENTAMIDINE; PYRROLE DERIVATIVE; RIFAMPICIN; VORICONAZOLE;

ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CANDIDA; CANDIDIASIS; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EARLY DIAGNOSIS; FEVER; GASTROINTESTINAL SYMPTOM; GRANULOCYTE; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFECTION RISK; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN;

EID: 0035721689     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.supplement-2.181     Document Type: Conference Paper

References (62)

1. Fungal infections in cancer patients: An international autopsy survey
2. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
3. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
4. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
5. Practical modalities for prevention of fungal infections in cancer patients
6. Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults
7. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation
8. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes
9. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
10. Association of Torulopsis glabrata infections in neutropenic bone marrow transplantation patients
11. Lung abscess due to Pseudallescheria boydii in the course of acute leukaemia. Report of a case and review of the literature
12. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management
13. Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases
14. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis
15. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
16. Significance of isolation of aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study
17. Hepatic candidiasis in cancer patients: The evolving picture of the syndrome
18. Computerized tomography in the diagnosis of systemic candidiasis in patients with acute leukemia
19. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients
20. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies
21. Prediction of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients
22. Candida colonization and systemic infection in neutropenic patients
23. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
24. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - A Prospective, randomized double blind study
25. Preventing fungal infection in neutropenic patients with acute leukemia: Fluconazole compared with oral amphotericin B
26. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematological malignancies and intensive chemotherapy. A double blind, placebo controlled study
27. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia: A randomized, double-blind, double-placebo multicenter trial comparing itraconazole and amphotericin B
28. Aerosol amphotericin B inhalations for the prevention of invasive pulmonary aspergillosis in neutropenic cancer patients
29. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis
30. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy
31. An approach to intensive antileukemic therapy in patients with previous invasive aspergillosis
32. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: Thirteen years experience
33. NIAID mycosis study group multicenter trial of oral itraconazole therapy for invasive aspergillosis
34. Non-candidal fungal infections after bone marrow transplantation: Risk factors and outcome
35. Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven mycoses in neutropenic patients
36. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
37. Empiric antifungal therapy in febrile neutropenic patients
38. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
39. A randomised comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
40. Liposomal amphotericin B for empirical therapy in patients with persisting fever and neutropenia
41. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: A pragmatic, multicentre, prospective and randomized trial
42. International conference for the development of a consensus on the management and prevention of severe candidal infections
43. Hepatosplenic candidiasis: Successful treatment with fluconazole
44. An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for a hematological malignancy
45. Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and a review of the literature
46. Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species
47. Practice guidelines for the treatment of candidiasis
48. High-dose fluconazole therapy in patients with severe fungal infections
49. Candida lusitaniae: Frequency of recover, colonization, infection, and amphotericin B resistance
50. Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients
51. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies
52. The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses
53. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
54. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data
55. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections
56. An EORTC multicenter randomised trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis
57. A randomized, double blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
58. Itraconazole as salvage therapy in invasive pulmonary aspergillosis occurring during amphotericin B therapy in neutropenic patients
59. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases
60. Management of invasive pulmonary aspergillosis in hematology patients: A review of 87 consecutive cases at a single institution
61. Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases
62. Amphotericin B lipid complex (Abelcet®) in the treatment of invasive mycoses: The North American experience